Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells

Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells

(2012) Won Seok Yang et al.   EXPERIMENTAL CELL RESEARCH

NF-κB and the link between inflammation and cancer

(2012) Joseph A. DiDonato et al.   IMMUNOLOGICAL REVIEWS

Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-κB via targeting of Mre11

(2011) Jing Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

(2010) Marion T Weigel et al.   BMC CANCER

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

(2009) Koh Miura et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Temporal trends in breast cancer mortality by state and race

(2008) Carol DeSantis et al.   CANCER CAUSES & CONTROL

Active roles for inhibitory  B kinases   and   in nuclear factor- B-mediated chemoresistance to doxorubicin

(2008) B. K. Bednarski et al.   MOLECULAR CANCER THERAPEUTICS